To evaluate the efficacy and safety of somatostatin or somatostatin analogues in the treatment of acute NVUGI bleeding by systematic review and meta-analysis of RCTs.
This is a protocol.
Somatostatin or somatostatin analogues for acute non-variceal upper gastrointestinal bleeding
You may also be interested in:
- Somatostatin analogues for carcinoid syndrome
- Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage
- What is the best regimen of proton pump inhibitors for bleeding peptic ulcers?
- Interventions for preventing upper gastrointestinal bleeding in people on intensive care units
- Somatostatin analogues for acute bleeding oesophageal varices
Health topics: